Chemists in the College of Arts and Sciences have figured out how to turn bacterial molecules into potential drug molecules.
Yan-Yeung Luk, associate professor of chemistry, and his research team have published their findings in ChemBioChem (John Wiley & Sons, 2015), explaining how they have created molecules that mimic and dominate toxic ones secreted by bacteria.
The implications for the study of biology and pharmacology are said to be enormous.
“Using toxic molecules to develop therapeutic agents, such as a vaccine, is not easy,” says Luk, who works at the interface of organic chemistry and the life sciences. “We’re just beginning to understand how some molecules—synthetic or naturally occurring—control the activities of bacteria. This will help us develop, among other things, drugs with many different applications.”
The Luk Research Group is focusing its attention on Pseudomonas aeruginosa, a microbe that causes many diseases and illnesses, including cystic fibrosis. Like other bacteria, P. aeruginosa produces a range of molecules that guides various activities. Among these molecules are rhamnolipids, which are made up of rhamnose sugar rings and fatty acids, and are able to reduce the surface tension of water. While rhamnolipids have been studied for decades, scientists don’t really know how they affect bacterial behavior.
Enter Luk, who, along with his research team, designs molecules that control such behavior. Their latest creation is a class of molecules called synthetic disaccharide derivatives (DSDs), which take over the chemical signaling of rhamnolipids to control activities such as biofilm formation, bacterial adhesion and swarming motility.
Lead author Nischal Singh G’15 and the rest of the Luk team have also discovered a subset of DSDs that dominates the function of rhamnolipids, and has demonstrated capacity for a range of new, unexpected bioactivities. The latter includes phenotypic switching, in which bacteria abandon their original phenotypes to “change” into two different phenotypes, and bacterial adhesion, considered the first step in colonization and biofilm formation.
“Biologists know how rhamnopilids are made by bacteria, and can knock out their production, but they don’t fully understand how rhamnolipids work—specifically, how they control different types of bacterial activities,” Luk says.
In addition to being non-toxic and biodegradable, rhamnolipids can withstand extreme temperatures, salinity and acidity. As a result, they have many useful chemical and biological properties.
Luk says that developing rhamnolipids into therapeutic agents has been speculated about for years, but without successful results. He hopes his group’s synthetic rhamnolipids approach is the exception. After designing and synthesizing two chemical libraries, or collections, of molecules, Luk’s third one contained two DSDs whose structures dominated the functions of rhamnolipids, offering the potential for many applications. It is from these two molecules that Luk’s team is making new ones.
The Latest on: Rhamnolipids
via Google News
The Latest on: Rhamnolipids
- Biotechnology progresson May 20, 2020 at 5:00 pm
The prevention of an anomalous chromatographic behavior and the resulting successful removal of viruses from monoclonal antibody with an asymmetric charge distribution by using a membrane adsorber ...
- Shale Solutions: Biosurfactants—the Future of Cost-effective Flow Assuranceon May 18, 2020 at 7:01 pm
Customized green treatments are outperforming conventional treatments in sustainability and more effective oil recovery.
- RushNet, Inc. (RSHN) And XYZ Hemp, Inc. (GRPS) Provide Annual Update Concerning Progress and Their Futureon May 18, 2020 at 6:07 pm
Before it's here, it's on the Bloomberg Terminal.
- Biotechnology letterson May 18, 2020 at 5:00 pm
Comparative RNA sequencing based transcriptome profiling of regular bearing and alternate bearing mango (Mangifera indica L.) varieties reveals novel insights into the regulatory mechanisms ...
- Strawberry fatty acyl glycosides enhance disease protection, have antibiotic activity and stimulate plant growthon May 17, 2020 at 5:00 pm
Induction of defense-related genes in Arabidopsis was also associated with SAGs-treatment as expression levels of PR1 gene, a genetic marker for the salicylic acid defense pathway, significantly ...
- The production of rhamnolipid biosurfactant by Pseudomonas aeruginosa growing in biofilms.on May 7, 2020 at 5:00 pm
However, P. aeruginosa is a human pathogen and the rhamnolipids also play an important role in pathogenicity including the development of biofilms. Most of the research on production of the ...
- Global Microbial Biosurfactants Market 2020, Forecast to 2026 Research Report Published by MarketsandResearch.bizon April 9, 2020 at 5:15 am
This report segments the global market on the basis of types are: Rhamnolipids, Sophorolipids, Mannosylerythritol Lipids (MEL), Others On the basis of application, the global market is segmented ...
- A natural control method for scab?on March 20, 2020 at 10:03 am
After treatment with the product, potato scab was eliminated in the test field as a result of the synergistic action of the rhamnolipids and other naturally derived ingredients in it, helping to ...
- Investigation of the diversity and role of rhamnosyltransferase enzymes in rhamnolipid synthesis in bacteria.on January 30, 2018 at 3:57 pm
Rhamnolipids have been identified as microbial biosurfactants with huge potential for industrial exploitation, however, the best known producer, Pseudomonas aeruginosa is a human pathogen and ...
via Bing News